BioNTech Balance Sheet Health
Financial Health criteria checks 5/6
BioNTech has a total shareholder equity of €18.4B and total debt of €1.9M, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are €22.7B and €4.3B respectively. BioNTech's EBIT is €12.6B making its interest coverage ratio 1685.4. It has cash and short-term investments of €13.4B.
Key information
0.01%
Debt to equity ratio
€1.90m
Debt
Interest coverage ratio | 1685.4x |
Cash | €13.43b |
Equity | €18.37b |
Total liabilities | €4.29b |
Total assets | €22.66b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 22UA's short term assets (€21.3B) exceed its short term liabilities (€4.0B).
Long Term Liabilities: 22UA's short term assets (€21.3B) exceed its long term liabilities (€336.6M).
Debt to Equity History and Analysis
Debt Level: 22UA has more cash than its total debt.
Reducing Debt: Insufficient data to determine if 22UA's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 22UA's debt is well covered by operating cash flow (660457.9%).
Interest Coverage: 22UA's interest payments on its debt are well covered by EBIT (1685.4x coverage).